Abstract 3470: Ibrutinib and sorafenib synergistically inhibit HCC growth in preclinical models
Year: 2018
Type: conference-abstract
Source: Cancer Research
Institution: The Ohio State University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2886768520
